Secondary surge continues as Peak XV moves to monetise Healthkart stake

Temasek-backed nutritional supplements and healthcare products manufacturer HealthKart is in talks with private equity firm ChrysCapital to raise about $100 million in a largely secondary round at a flat valuation, multiple people aware of the matter told The CapTable. HealthKart was last valued at $350 million.

Peak XV Partners (formerly Sequoia Capital India) is looking to sell the majority of its nearly 30% stake in the round, the sources said, requesting anonymity as the discussions are private. Last year, ChrysCapital also invested in Lenskart, giving SoftBank, Chiratae Ventures, and other early backers of the eyewear company partial exits.

HealthKart has been in the market for funding for over six months to facilitate Peak XV’s exit, the people added. Investment bank Avendus Capital is advising HealthKart for the deal. “The contours are yet to be finalised. Sequoia (Peak XV) might even fully exit if it gets a good deal,” said one of the people quoted above.